HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ILMN
Illumina Inc
Healthcare Diagnostics & Research · California, USA · Reports in usd
Market Cap: $19.54B
Market Cap
$19.54B
Enterprise Val
$20.38B
P/E Ratio
22.99
P/B Ratio
7.18
Trailing PEG (1Y)
0.27
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 28, 2025 · Q4 2025
Book Value$2.72B
Gross Margin65.49%
Profit Margin65.49%
Return on Equity34.94%
Return on Assets13.55%
Current Ratio2.08
Debt/Equity0.91
LT Debt/Equity0.73
Revenue Per Share7.59

Income Statement

Dec 28, 2025
Revenue$1.16B
Cost of Revenue$400.0M
Gross Profit$759.0M
R&D$239.0M
SG&A$309.0M
Operating Expenses$558.0M
Operating Income$201.0M
Interest Expense$26.0M
Tax Expense$43.0M
Net Income$334.0M
EPS (Basic)$2.17
EPS (Diluted)$2.16
EBIT$403.0M
EBITDA$469.0M
Consolidated Income$334.0M
Non-Controlling Interests$0.00

Balance Sheet

Dec 28, 2025
Cash & Equivalents$1.42B
Accounts Receivable$854.0M
Inventory$564.0M
Current Assets$3.29B
LT Investments$0.00
Property, Plant & Equipment$1.13B
Intangibles$1.32B
Non-Current Assets$3.36B
Total Assets$6.64B
Accounts Payable$240.0M
Current Debt$499.0M
Current Liabilities$1.59B
LT Debt$1.98B
Non-Current Liabilities$2.34B
Total Liabilities$3.92B
Total Debt$2.48B
Retained Earnings-$392.0M
Shareholder Equity$2.72B
Shares Outstanding152,800,000

Cash Flow Statement

Dec 28, 2025
Operating Cash Flow$321.0M
Investing Cash Flow$108.0M
Financing Cash Flow-$63.0M
CapEx-$55.0M
Free Cash Flow$266.0M
Depreciation & Amort.$66.0M
Stock-Based Comp$63.0M
Acquisitions / Disposals-$3.0M
Investment Activity$166.0M
Debt Issued/Repaid-$5.0M
Equity Issued/Repaid-$42.0M
Dividends Paid$0.00
Net Change in Cash$368.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h